WestView Capital, a private equity firm, completed the $73m investment in Kymanox, a provider of life sciences consulting services to biotechnology, pharmaceutical and medical companies. “We are excited to partner with WestView and leverage their deep experience as investors in both the life science industry and people-based businesses. As we enter this next phase of growth together, Kymanox will expand the depth and breadth of our service offerings to meet the growing needs of our clients and the industry as a whole," Stephen M. Perry, Kymanox Founder and CEO.